| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Phac1g02834 | ATGCTCCACTCTTCGCTAACTCTTCTCTTCACCCTCCTCTTTTCCCTCACCACTGCCGACCCGCACGAAGTCGAAATACTGCGGCAATTCCGAAACGGGTTGGACAACCCGGACCTGTTGCCGTGGCCGGACAGCGGCGATGACCCGTGTGCTTGGAAGTACATTTTCTGCGACAATAAGAACCGTGTGAACCAGATTCAGGCGAAGGGGTTGAACCTGAGCGGTCCTCTGGCGCCGAACCTGAACCAGCTCACGAATCTCTTCAACGTGGGCCTCCAGAACAACAGGCTTAACGGTCCATTACCCTCCTTCCGCGGCTTGTCAAATCTCAAATACTTGTATCTTGACAACAACAACTTTGACTCCATCCCTTCAGATTTCTTTGACGGGCTCCAGAGTTTGGAAGTGCTCGCGTTGGACAATAATGACCTCAACGCCAGCTCTGGTGGCTGGCACTTACCGCAGACGCTCCAGGAGTCAACGCAGTTGACCAATCTCTCCTGCATGGGCTGCAACCTCGCCGGCCCATTACCGGAGTTTCTCGGAACGATGAACTCGCTGTCGTTTTTGAAGCTCTCCAACAACAACTTAACGGGCGAGATTCCCCTGAGTCTAAACGACTCCGCGTTGCAGGTTCTCTGGCTGAATAACCAGCGGGGGGAGTGTCTTTCTGGAAGAATTGACGTTGTGGCCTCCATGGTTTCGCTCACGAGTTTGTGGCTTCACGGGAACTCGTTCACTGGAACGATTCCCGATAACATTGGGGATTTGAGCTCTCTACGGGAACTTAACCTTAATGGGAACAACCTCGTTGGGTTGGTTCCTCAAGGTTTGGGTGAGTTGAAGCTGGACAAGCTGGACTTGAACAACAACCATTTTATGGGTCCGATTCCCAATTTTAAAGCGGTTCAAGTGTCTTATGATTTTAACAATTTTTGTGTGAACAAGTCAGGGGTTCCTTGCGCGTTTGAGGTGACGGCGCTGTTGGGGTTTCTTGGGGGGTTGAATTATCCTGAGAATTTGGTTAATTCGTGGAGTGGGAATGATCCTTGTGGGGGTCAGTGGTTGGGGATAAAGTGTAATGTTGATGGAAAGGTGAATATGATTAATTTGCCTAATTTGAATCTTAGTGGGAGTTTAAGTCCTTCTGTTGCGAACTTGGGTTCTCTTGTTGAGATTAGGTTGGGGGGGAATGATATTAGTGGTACGGTGCCTGGTAATTGGAGTAGTTTGACATCTTTGAAATTGTTGGATCTGAGTGGAAATAACATTTCTCCTCCATTGCCTTTGTTTAAGACTGGATTGAAACCTATTGTTACTGGGAATCCCCTCTTTAATGGTGGTGCCGAAAATCCTTCATCAGGGAGCAAGAACCCATCATCTGGATCTGGGAATGTCGACCCTGCATCCGGTCAGTCCAATTCTAGTTCGACTGATTCCCTTGAAACTAAGAAATCTAAACGGAAAGGGTTGGTTTCCATTGTTGCTCCGATTGTGGGTGTGGCAGCTGCGGCTTTTCTGCTCATTCCACTCTATGCATATTGTTTCAAGAGCAGGAAGGGTGGCTTCCAGGCTCCAACCTCACTGGTAATTCACCCTAGGGATCCATCGTATTCGGACAGTGTTGTGAAGATTGCTGTTGCTAACAATACCAATGGAAGCATTTCCACTTTGACAGGGAGTGGTTCTGGGAGTAGGAATAGTAGTGGGAATGGGGAGTCTCATGTCATTGACGCTGGAAATCTTAGAATATCAGTTCAAGTTCTCAGGAACGTGACCAAGAATTTTGCGCCCGAGAATGAGCTTGGCCGTGGTGGATTTGGAGTTGTTTATAAGGGAGAGTTGGATGATGGAACTAAAATTGCAGTGAAACGAATGGAAGCTGGTGTGATTAGTAGCAAGGCATTGGATGAATTCCAGGCCGAGATTGCGGTTCTATCAAAAGTCCGGCACCGGCATCTGGTGTCTCTTTTGGGTTATTCTATAGAAGGTAATGAAAGGATTCTGGTGTATGAATATATGCCACAAGGGGCTCTAAGTAAGCATCTTTTCCATTGGAAAAGCCATGAACTGGAGCCACTCTCTTGGAAGAGGAGGCTCAATATTGCATTGGATGTTGCCAGAGGGATGGAGTATCTTCATACTCTGGCTCACCAGAGCTTCATTCACAGAGATCTTAAGCCGTCAAATATCTTGCTTGCTGATGATTTTAGAGCAAAGGTCTCAGATTTTGGTTTGGTAAAACTTGCTCCTGACGGTGAAAAATCTGTAGTTACCAGGCTTGCTGGGACTTTCGGATATTTGGCGCCAGAATATGCAGTGACAGGAAAAATCACTACCAAAGCAGATGTTTTCAGTTTCGGGGTTGTGCTAATGGAGCTATTGACTGGATTAATGGCACTTGATGAGGACAGACCTGAGGAAAGCCAATACTTAGCAGCGTGGTTCTGGAGTATAAAATCAGATAAGAAGAAGCTAATGGCTGCTATTGACAAAGTCCTTGATGTTAAGGAGGAAACATTTGAGAGCGTCTCCATCATTGCTGAGTTAGCAGGGCACTGCACAGCCAGAGAACCAGGCCAACGGCCAGAGATGGGTCATGCCGTAAATGTGCTGGCACCGCTTGTTGAAAAATGGAAACCCTTTGATGATGAGGCTGAGGAGTATTCCGGGATCGATTATAGCCTTCCCCTTAACCAGATGGTGAAGGGATGGCAAGAGGCAGAAGGAAAGGACATGAGTTATATGGACCTAGAAGACAGTAAGAGCAGTATCCCCGCAAGGCCTACTGGATTTGCAGATTCTTTCACTTCAGCTGATGGGCGTTGA | 2829 | 0.474 | MLHSSLTLLFTLLFSLTTADPHEVEILRQFRNGLDNPDLLPWPDSGDDPCAWKYIFCDNKNRVNQIQAKGLNLSGPLAPNLNQLTNLFNVGLQNNRLNGPLPSFRGLSNLKYLYLDNNNFDSIPSDFFDGLQSLEVLALDNNDLNASSGGWHLPQTLQESTQLTNLSCMGCNLAGPLPEFLGTMNSLSFLKLSNNNLTGEIPLSLNDSALQVLWLNNQRGECLSGRIDVVASMVSLTSLWLHGNSFTGTIPDNIGDLSSLRELNLNGNNLVGLVPQGLGELKLDKLDLNNNHFMGPIPNFKAVQVSYDFNNFCVNKSGVPCAFEVTALLGFLGGLNYPENLVNSWSGNDPCGGQWLGIKCNVDGKVNMINLPNLNLSGSLSPSVANLGSLVEIRLGGNDISGTVPGNWSSLTSLKLLDLSGNNISPPLPLFKTGLKPIVTGNPLFNGGAENPSSGSKNPSSGSGNVDPASGQSNSSSTDSLETKKSKRKGLVSIVAPIVGVAAAAFLLIPLYAYCFKSRKGGFQAPTSLVIHPRDPSYSDSVVKIAVANNTNGSISTLTGSGSGSRNSSGNGESHVIDAGNLRISVQVLRNVTKNFAPENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISSKALDEFQAEIAVLSKVRHRHLVSLLGYSIEGNERILVYEYMPQGALSKHLFHWKSHELEPLSWKRRLNIALDVARGMEYLHTLAHQSFIHRDLKPSNILLADDFRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVTGKITTKADVFSFGVVLMELLTGLMALDEDRPEESQYLAAWFWSIKSDKKKLMAAIDKVLDVKEETFESVSIIAELAGHCTAREPGQRPEMGHAVNVLAPLVEKWKPFDDEAEEYSGIDYSLPLNQMVKGWQEAEGKDMSYMDLEDSKSSIPARPTGFADSFTSADGR* | 943 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Phac1g02834 | 942 | Gene3D | Ribonuclease Inhibitor | 20 | 319 | IPR032675 | - | |
| Phac1g02834 | 942 | ProSiteProfiles | Leucine-rich repeat profile. | 109 | 130 | IPR001611 | GO:0005515 | |
| Phac1g02834 | 942 | SUPERFAMILY | L domain-like | 20 | 300 | - | - | |
| Phac1g02834 | 942 | Gene3D | Ribonuclease Inhibitor | 323 | 443 | IPR032675 | - | |
| Phac1g02834 | 942 | FunFam | Receptor-like kinase TMK4 | 21 | 318 | - | - | |
| Phac1g02834 | 942 | FunFam | Leucine-rich repeat receptor-like kinase | 323 | 447 | - | - | |
| Phac1g02834 | 942 | ProSiteProfiles | Protein kinase domain profile. | 596 | 876 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Phac1g02834 | 942 | SUPERFAMILY | Protein kinase-like (PK-like) | 573 | 872 | IPR011009 | - | |
| Phac1g02834 | 942 | ProSitePatterns | Protein kinases ATP-binding region signature. | 602 | 624 | IPR017441 | GO:0005524 | |
| Phac1g02834 | 942 | FunFam | receptor protein kinase TMK1 | 558 | 673 | - | - | |
| Phac1g02834 | 942 | MobiDBLite | consensus disorder prediction | 442 | 484 | - | - | |
| Phac1g02834 | 942 | Pfam | Leucine rich repeat N-terminal domain | 324 | 361 | IPR013210 | - | |
| Phac1g02834 | 942 | Pfam | Leucine rich repeat N-terminal domain | 22 | 58 | IPR013210 | - | |
| Phac1g02834 | 942 | MobiDBLite | consensus disorder prediction | 916 | 942 | - | - | |
| Phac1g02834 | 942 | Pfam | Leucine rich repeat | 235 | 293 | IPR001611 | GO:0005515 | |
| Phac1g02834 | 942 | Pfam | Leucine rich repeat | 87 | 144 | IPR001611 | GO:0005515 | |
| Phac1g02834 | 942 | Gene3D | Transferase(Phosphotransferase) domain 1 | 674 | 892 | - | - | |
| Phac1g02834 | 942 | SMART | serkin_6 | 596 | 876 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Phac1g02834 | 942 | PANTHER | OSJNBA0070M12.3 PROTEIN | 6 | 942 | - | - | |
| Phac1g02834 | 942 | MobiDBLite | consensus disorder prediction | 446 | 480 | - | - | |
| Phac1g02834 | 942 | Pfam | Protein tyrosine and serine/threonine kinase | 599 | 870 | IPR001245 | GO:0004672|GO:0006468 | |
| Phac1g02834 | 942 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 721 | 733 | IPR008271 | GO:0004672|GO:0006468 | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 131 | 160 | IPR003591 | - | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 184 | 208 | IPR003591 | - | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 233 | 256 | IPR003591 | - | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 257 | 280 | IPR003591 | - | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 107 | 130 | IPR003591 | - | |
| Phac1g02834 | 942 | SMART | LRR_typ_2 | 411 | 433 | IPR003591 | - | |
| Phac1g02834 | 942 | SUPERFAMILY | L domain-like | 324 | 434 | - | - | |
| Phac1g02834 | 942 | Gene3D | Phosphorylase Kinase; domain 1 | 561 | 673 | - | - | |
| Phac1g02834 | 942 | FunFam | receptor protein kinase TMK1 | 674 | 891 | - | - | |
| Phac1g02834 | 942 | CDD | STKc_IRAK | 602 | 875 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Phac1g02834 | Phac-Chr1 | 37340750 | 37344398 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Phac1g02834 | 73 | 877 | Receptor kinase-like Gene Family | AT5G07280 | 33.028 | 2.52e-79 | 279 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-IX | Phac1g02834 | PK_Tyr_Ser-Thr | 1.8e-46 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Phac1g02834 | - | - | gmx:100305366 | 1562.36 |